Robert Hodgkinson Acquires 75,000 Shares of VentriPoint Diagnostics Ltd. (CVE:VPT) Stock

VentriPoint Diagnostics Ltd. (CVE:VPT) Director Robert Hodgkinson acquired 75,000 shares of the company’s stock in a transaction dated Monday, April 22nd. The stock was acquired at an average price of C$0.21 per share, with a total value of C$15,900.00.

Robert Hodgkinson also recently made the following trade(s):

• On Thursday, April 18th, Robert Hodgkinson acquired 36,500 shares of VentriPoint Diagnostics stock. The stock was acquired at an average price of C$0.21 per share, with a total value of C$7,774.50.

VentriPoint Diagnostics Trading Up 4.8 %

Shares of VPT stock opened at C$0.22 on Wednesday. VentriPoint Diagnostics Ltd. has a 52-week low of C$0.12 and a 52-week high of C$0.36. The stock has a market cap of C$34.50 million, a price-to-earnings ratio of -7.33 and a beta of 0.39. The company has a debt-to-equity ratio of 32.61, a quick ratio of 6.67 and a current ratio of 2.06. The firm has a fifty day moving average of C$0.25 and a 200-day moving average of C$0.24.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.